| Dr Steve Yu, MD | |
|
8911 Shady Grove Ct, Gaithersburg, MD 20877-1308 | |
| (301) 963-0900 | |
| (301) 963-9694 |
| Full Name | Dr Steve Yu |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 8911 Shady Grove Ct, Gaithersburg, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710929724 | NPI | - | NPPES |
| 721771 | Other | MD | MEDICARE PTAN |
| 183451700 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D39776 (Maryland) | Primary |
| Entity Name | Steve Yu Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538397476 PECOS PAC ID: 6507993573 Enrollment ID: O20100422000789 |
News Archive
The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).
A new study by scientists at the U.S. Department of Energy's Brookhaven National Laboratory and colleagues in Norway suggests that the benefits of moderately increased exposure to sunlight - namely the production of vitamin D, which protects against the lethal effects of many forms of cancer and other diseases - may outweigh the risk of developing skin cancer in populations deficient in vitamin D.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
Epilepsy is one of the most common neurological disorders, affecting over 50 Million people worldwide. Patients suffer from seizures caused by sudden neuronal activity engaging at times large networks of the brain.
The pharmaceutical industry is a "market for lemons," a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and less safe than consumers are led to believe, according to an analysis that will be presented at the 105th Annual Meeting of the American Sociological Association.
› Verified 6 days ago
| Entity Name | Obhg Maryland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851657894 PECOS PAC ID: 3577728211 Enrollment ID: O20220103000291 |
News Archive
The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).
A new study by scientists at the U.S. Department of Energy's Brookhaven National Laboratory and colleagues in Norway suggests that the benefits of moderately increased exposure to sunlight - namely the production of vitamin D, which protects against the lethal effects of many forms of cancer and other diseases - may outweigh the risk of developing skin cancer in populations deficient in vitamin D.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
Epilepsy is one of the most common neurological disorders, affecting over 50 Million people worldwide. Patients suffer from seizures caused by sudden neuronal activity engaging at times large networks of the brain.
The pharmaceutical industry is a "market for lemons," a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and less safe than consumers are led to believe, according to an analysis that will be presented at the 105th Annual Meeting of the American Sociological Association.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steve Yu, MD 8911 Shady Grove Ct, Gaithersburg, MD 20877-1308 Ph: (301) 963-0900 | Dr Steve Yu, MD 8911 Shady Grove Ct, Gaithersburg, MD 20877-1308 Ph: (301) 963-0900 |
News Archive
The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).
A new study by scientists at the U.S. Department of Energy's Brookhaven National Laboratory and colleagues in Norway suggests that the benefits of moderately increased exposure to sunlight - namely the production of vitamin D, which protects against the lethal effects of many forms of cancer and other diseases - may outweigh the risk of developing skin cancer in populations deficient in vitamin D.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
Epilepsy is one of the most common neurological disorders, affecting over 50 Million people worldwide. Patients suffer from seizures caused by sudden neuronal activity engaging at times large networks of the brain.
The pharmaceutical industry is a "market for lemons," a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and less safe than consumers are led to believe, according to an analysis that will be presented at the 105th Annual Meeting of the American Sociological Association.
› Verified 6 days ago
Dr. Shen-sho Tseng, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9075 Shady Grove Ct, Gaithersburg, MD 20877 Phone: 301-212-9447 Fax: 301-212-9713 | |
Dr. Stacey Anderson Garrett, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 655 Watkins Mill Rd, Gaithersburg, MD 20879 Phone: 240-632-4000 | |
Dr. Farzaneh Lolachi Sabi, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 855 Watkins Mill Road, Kaiser Permanente Gaithersburg Medical Center, Gaithersburg, MD 20879 Phone: 240-632-4000 | |
Dr. Angela D Thompson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 501 N Frederick Ave, Kaiser Permanente Medical Center, Gaithersburg, MD 20877 Phone: 301-258-7700 Fax: 301-258-7293 | |
Karishma Shailesh Patel, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 501 N Frederick Ave, Gaithersburg Medical Center, Gaithersburg, MD 20877 Phone: 301-258-7700 | |
Nina Vann Jeanes, M.D., PC Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 201 Russell Ave, Gaithersburg, MD 20877 Phone: 301-216-4157 Fax: 301-987-6297 | |
Dr. Heather Marie Murphy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 655 Watkins Mill Rd, Gaithersburg, MD 20879 Phone: 240-632-4000 |